Congenital Cytomegalovirus Rx for Prevention article with CME

Original release date: April 30, 2025.   Termination date: April 29, 2028.

Continuing Education Credit(s)

This enduring material has been approved for 0.5 AMA PRA Category 1 Credit™.

To request a certificate, you must first read the cCMV article and then complete this form. Physicians will receive a CME Certificate and other learners will receive a Certificate of Attendance.* 

Article Summary

Congenital cytomegalovirus (cCMV) is the most common infectious cause of birth defects and the leading cause of non-genetic sensorineural hearing loss. Early diagnosis and treatment of infants helps improve outcomes. cCMV was recently added to the Los Angeles County Reportable Diseases and Conditions list.

This Rx for Prevention article covers the background, clinical presentation, diagnosis, management, and reporting of cCMV, as well as the importance of surveillance and reporting. It also includes a summary of key steps for recognizing and reporting cCMV.

Target Audience

The target audience is physicians and other health care providers practicing in Los Angeles County.

Learning Objectives

At the conclusion of the article, the learner will feel more confident in their ability to:
  1. Recognize clinical signs and symptoms of cCMV
  2. Conduct appropriate testing for cCMV
  3. Initiate appropriate evaluations and referrals for children newly diagnosed with cCMV
  4. Report cases of cCMV to the Los Angeles County Department of Public Health

Authors

Neema Pithia, MD. Neonatologist / Infectious Disease Fellow, University of California - Los Angeles
Umme-Aiman Halai, MD, MPH. Medical Epidemiologist, Los Angeles County Department of Public Health, Acute Communicable Disease Control Program

Accreditation Statement

California Medical Association accredited CME provider logo

The Los Angeles County Department of Public Health is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.

The Los Angeles County Department of Public Health designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

*Other learners receive a Certificate of Attendance. Participation in CE coursework designated for AMA PRA Category 1 Credits™ is considered acceptable CE by the CA Board of Registered Nursing and the CA Board of Pharmacy if the coursework pertains to the practice of nursing or pharmacy respectively. Please contact your board with questions.

Disclosure

No relevant financial relationships were disclosed by the authors or the planners. This activity is offered by an accredited CMA-CME provider and is not commercially supported.

Contact Information